These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 32394498)
41. Individual participant data meta-analysis for a binary outcome: one-stage or two-stage? Debray TP; Moons KG; Abo-Zaid GM; Koffijberg H; Riley RD PLoS One; 2013; 8(4):e60650. PubMed ID: 23585842 [TBL] [Abstract][Full Text] [Related]
42. Comparison of one-step and two-step meta-analysis models using individual patient data. Mathew T; Nordström K Biom J; 2010 Apr; 52(2):271-87. PubMed ID: 20349448 [TBL] [Abstract][Full Text] [Related]
43. Performance of analytical methods for overdispersed counts in cluster randomized trials: sample size, degree of clustering and imbalance. Durán Pacheco G; Hattendorf J; Colford JM; Mäusezahl D; Smith T Stat Med; 2009 Oct; 28(24):2989-3011. PubMed ID: 19672840 [TBL] [Abstract][Full Text] [Related]
44. Appropriate statistical methods for analysing partially nested randomised controlled trials with continuous outcomes: a simulation study. Candlish J; Teare MD; Dimairo M; Flight L; Mandefield L; Walters SJ BMC Med Res Methodol; 2018 Oct; 18(1):105. PubMed ID: 30314463 [TBL] [Abstract][Full Text] [Related]
45. Two-stage targeted maximum likelihood estimation for mixed aggregate and individual participant data analysis with an application to multidrug resistant tuberculosis. Siddique AA; Schnitzer ME; Balakrishnan N; Sotgiu G; Vargas MH; Menzies D; Benedetti A Stat Med; 2024 Jan; 43(2):342-357. PubMed ID: 37985441 [TBL] [Abstract][Full Text] [Related]
46. Evaluating treatment effectiveness under model misspecification: A comparison of targeted maximum likelihood estimation with bias-corrected matching. Kreif N; Gruber S; Radice R; Grieve R; Sekhon JS Stat Methods Med Res; 2016 Oct; 25(5):2315-2336. PubMed ID: 24525488 [TBL] [Abstract][Full Text] [Related]
47. Adjusting for misclassification of an exposure in an individual participant data meta-analysis. de Jong VMT; Campbell H; Maxwell L; Jaenisch T; Gustafson P; Debray TPA Res Synth Methods; 2023 Mar; 14(2):193-210. PubMed ID: 36200133 [TBL] [Abstract][Full Text] [Related]
49. Longitudinal Joint Modelling of Ordinal and Overdispersed Count Outcomes: A Bridge Distribution for the Ordinal Random Intercept. Amini P; Moghimbeigi A; Zayeri F; Tapak L; Maroufizadeh S; Verbeke G Comput Math Methods Med; 2021; 2021():5521881. PubMed ID: 33763151 [TBL] [Abstract][Full Text] [Related]
50. An assessment of estimation methods for generalized linear mixed models with binary outcomes. Capanu M; Gönen M; Begg CB Stat Med; 2013 Nov; 32(26):4550-66. PubMed ID: 23839712 [TBL] [Abstract][Full Text] [Related]
51. REML estimation for survival models with frailty. McGilchrist CA Biometrics; 1993 Mar; 49(1):221-5. PubMed ID: 8513103 [TBL] [Abstract][Full Text] [Related]
52. Extended information criterion (EIC) approach for linear mixed effects models under restricted maximum likelihood (REML) estimation. Yafune A; Funatogawa T; Ishiguro M Stat Med; 2005 Nov; 24(22):3417-29. PubMed ID: 16237658 [TBL] [Abstract][Full Text] [Related]
53. Handling incomplete correlated continuous and binary outcomes in meta-analysis of individual participant data. Gomes M; Hatfield L; Normand SL Stat Med; 2016 Sep; 35(21):3676-89. PubMed ID: 27090498 [TBL] [Abstract][Full Text] [Related]
54. Multivariate meta-analysis using individual participant data. Riley RD; Price MJ; Jackson D; Wardle M; Gueyffier F; Wang J; Staessen JA; White IR Res Synth Methods; 2015 Jun; 6(2):157-74. PubMed ID: 26099484 [TBL] [Abstract][Full Text] [Related]
55. Efficient two-step multivariate random effects meta-analysis of individual participant data for longitudinal clinical trials using mixed effects models. Noma H; Maruo K; Gosho M; Levine SZ; Goldberg Y; Leucht S; Furukawa TA BMC Med Res Methodol; 2019 Feb; 19(1):33. PubMed ID: 30764757 [TBL] [Abstract][Full Text] [Related]
56. Estimating the variance for heterogeneity in arm-based network meta-analysis. Piepho HP; Madden LV; Roger J; Payne R; Williams ER Pharm Stat; 2018 May; 17(3):264-277. PubMed ID: 29676023 [TBL] [Abstract][Full Text] [Related]
57. Individual patient data meta-analysis of time-to-event outcomes: one-stage versus two-stage approaches for estimating the hazard ratio under a random effects model. Bowden J; Tierney JF; Simmonds M; Copas AJ; Higgins JP Res Synth Methods; 2011 Sep; 2(3):150-62. PubMed ID: 26061783 [TBL] [Abstract][Full Text] [Related]
58. A REML method for the evidence-splitting model in network meta-analysis. Piepho HP; Forkman J; Malik WA Res Synth Methods; 2024 Mar; 15(2):198-212. PubMed ID: 38037262 [TBL] [Abstract][Full Text] [Related]
59. A comparison of bootstrap approaches for estimating uncertainty of parameters in linear mixed-effects models. Thai HT; Mentré F; Holford NH; Veyrat-Follet C; Comets E Pharm Stat; 2013; 12(3):129-40. PubMed ID: 23457061 [TBL] [Abstract][Full Text] [Related]
60. Sensitivity analysis for publication bias in meta-analysis of sparse data based on exact likelihood. Hu T; Zhou Y; Hattori S Biometrics; 2024 Jul; 80(3):. PubMed ID: 39253987 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]